These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2565201)

  • 1. The covalent binding to protein of valproic acid and its hepatotoxic metabolite, 2-n-propyl-4-pentenoic acid, in rats and in isolated rat hepatocytes.
    Porubek DJ; Grillo MP; Baillie TA
    Drug Metab Dispos; 1989; 17(2):123-30. PubMed ID: 2565201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enantiotopic differentiation during the biotransformation of valproic acid to the hepatotoxic olefin 2-n-propyl-4-pentenoic acid.
    Porubek DJ; Barnes H; Meier GP; Theodore LJ; Baillie TA
    Chem Res Toxicol; 1989; 2(1):35-40. PubMed ID: 2519229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative investigation of 2-propyl-4-pentenoic acid (4-ene VPA) and its alpha-fluorinated analogue: phase II metabolism and pharmacokinetics.
    Tang W; Abbott FS
    Drug Metab Dispos; 1997 Feb; 25(2):219-27. PubMed ID: 9029053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biotransformation and pharmacokinetics in the rhesus monkey of 2-n-propyl-4-pentenoic acid, a toxic metabolite of valproic acid.
    Rettenmeier AW; Gordon WP; Prickett KS; Levy RH; Baillie TA
    Drug Metab Dispos; 1986; 14(4):454-64. PubMed ID: 2873993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the biotransformation in the perfused rat liver of 2-n-propyl-4-pentenoic acid, a metabolite of the antiepileptic drug valproic acid. Evidence for the formation of chemically reactive intermediates.
    Rettenmeier AW; Prickett KS; Gordon WP; Bjorge SM; Chang SL; Levy RH; Baillie TA
    Drug Metab Dispos; 1985; 13(1):81-96. PubMed ID: 2858383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytochrome P-450-mediated dehydrogenation of 2-n-propyl-2(E)-pentenoic acid, a pharmacologically-active metabolite of valproic acid, in rat liver microsomal preparations.
    Kassahun K; Baillie TA
    Drug Metab Dispos; 1993; 21(2):242-8. PubMed ID: 8097692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorinated analogues as mechanistic probes in valproic acid hepatotoxicity: hepatic microvesicular steatosis and glutathione status.
    Tang W; Borel AG; Fujimiya T; Abbott FS
    Chem Res Toxicol; 1995; 8(5):671-82. PubMed ID: 7548749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic activation of unsaturated derivatives of valproic acid. Identification of novel glutathione adducts formed through coenzyme A-dependent and -independent processes.
    Kassahun K; Hu P; Grillo MP; Davis MR; Jin L; Baillie TA
    Chem Biol Interact; 1994 Mar; 90(3):253-75. PubMed ID: 8168173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enantioselective synthesis and preliminary metabolic studies of the optical isomers of 2-n-propyl-4-pentenoic acid, a hepatotoxic metabolite of valproic acid.
    Porubek DJ; Barnes H; Theodore LJ; Baillie TA
    Chem Res Toxicol; 1988; 1(6):343-8. PubMed ID: 2979751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo formation of the thiol conjugates of reactive metabolites of 4-ene VPA and its analog 4-pentenoic acid.
    Kassahun K; Abbott F
    Drug Metab Dispos; 1993; 21(6):1098-106. PubMed ID: 7905390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereochemical studies on the beta-oxidation of valproic acid in isolated rat hepatocytes.
    Shirley MA; Hu P; Baillie TA
    Drug Metab Dispos; 1993; 21(4):580-6. PubMed ID: 8104116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative transfer of valproic acid and of an active metabolite into brain and liver: possible pharmacological and toxicological consequences.
    Löscher W; Nau H
    Arch Int Pharmacodyn Ther; 1984 Aug; 270(2):192-202. PubMed ID: 6435554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism of unsaturated derivatives of valproic acid in rat liver microsomes and destruction of cytochrome P-450.
    Prickett KS; Baillie TA
    Drug Metab Dispos; 1986; 14(2):221-9. PubMed ID: 2870898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic fate of valproic acid in the rhesus monkey. Formation of a toxic metabolite, 2-n-propyl-4-pentenoic acid.
    Rettenmeier AW; Gordon WP; Prickett KS; Levy RH; Lockard JS; Thummel KE; Baillie TA
    Drug Metab Dispos; 1986; 14(4):443-53. PubMed ID: 2873992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the beta-oxidation of valproic acid in rat liver mitochondrial preparations.
    Bjorge SM; Baillie TA
    Drug Metab Dispos; 1991; 19(4):823-9. PubMed ID: 1680661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and enterohepatic circulation of 2-n-propyl-4-pentenoic acid in the rat.
    Singh K; Orr JM; Abbott FS
    Drug Metab Dispos; 1988; 16(6):848-52. PubMed ID: 2907464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and characterization of the glutathione and N-acetylcysteine conjugates of (E)-2-propyl-2,4-pentadienoic acid, a toxic metabolite of valproic acid, in rats and humans.
    Kassahun K; Farrell K; Abbott F
    Drug Metab Dispos; 1991; 19(2):525-35. PubMed ID: 1676665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytochrome P-450-catalyzed desaturation of valproic acid in vitro. Species differences, induction effects, and mechanistic studies.
    Rettie AE; Boberg M; Rettenmeier AW; Baillie TA
    J Biol Chem; 1988 Sep; 263(27):13733-8. PubMed ID: 3138238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative pharmacodynamics and brain distribution of E-delta 2-valproate and valproate in rats.
    Semmes RL; Shen DD
    Epilepsia; 1991; 32(2):232-41. PubMed ID: 2004628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of the role of in situ generated (E)-2,4-diene-valproic acid in the toxicity of valproic acid and (E)-2-ene-valproic acid in sandwich-cultured rat hepatocytes.
    Surendradoss J; Chang TK; Abbott FS
    Toxicol Appl Pharmacol; 2012 Nov; 264(3):413-22. PubMed ID: 22940460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.